Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Recruiting 2

Sponsor Class

OTHER 1FED 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Gastrointestinal 1

Conditions

Neoplasms 1Motor Activity 1Esophageal Neoplasms 1

Interventions

Specimen Handling 267Magnetic Resonance Spectroscopy 218pembrolizumab 203Carboplatin 170Cisplatin 137Biopsy 136Cyclophosphamide 131Paclitaxel 120Nivolumab 110Bevacizumab 104Gemcitabine 102Radiotherapy 85Dexamethasone 77Pemetrexed 75atezolizumab 73Fluorouracil 71fludarabine 69Doxorubicin 68Leucovorin 66Docetaxel 66Radiation 65Oxaliplatin 62Rituximab 60venetoclax 58Prednisone 58Cetuximab 54durvalumab 53Vincristine 52Etoposide 51130-nm albumin-bound paclitaxel 51

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Nutritional Status × 30 days × Clear all
NCT06872515 2026-05-26

Impact of Prehabilitation in Oncology Via Exercise- Esophageal (IMPROVE-Esophageal)

University of Pittsburgh

Phase NA Recruiting
20 enrolled
Gastrointestinal

Esophageal Neoplasms, Motor Activity

NCT05912257 2026-05-20

NOSH

VA Office of Research and Development

Phase NA Recruiting
188 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡